Significantly more patients with acute ischemic stroke achieved primary outcome of 0 or 1 on modified Rankin scale at 90 days.

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...

International Stroke Conference of the American Heart Association/American Stroke Association was held from Feb. 5 to 7 in ...

Endovascular thrombectomy (EVT) does not lead to better outcomes at 90 days compared with usual care or best medical treatment for patients with acute ischemic stroke due to medium vessel occlusion.

Transplantation of neural stem cells improved neurologic and motor function for adults with chronic ischemic stroke at 12 ...

Remedy Pharmaceuticals, a leader in stroke drug development today announced efficacy data from the Phase 2 GAMES-RP and Phase 3 CHARM studies of CIRARA (intravenous glyburide) for the treatment of ...

In a recent study evaluating the impact of coma duration on functional outcomes and long-term survival after cardiac arrest, ...

The standard treatment for these strokes involves removing the clot using a thin tube (catheter) or a stent, a procedure ...

Background It is uncertain whether mechanical thrombectomy (MT) increases the probability of a good outcome (modified Rankin Scale (mRS) 0–2) in patients with Alberta Stroke Program Early CT Score ...

Determine if you'd like your smart scale to connect to Wi-Fi, Bluetooth or both. User-friendly interface You want a smart scale that has an interface that's easy to read and follow. Especially if ...

Cerebral venous thrombosis is a rare but potentially life-threatening condition that is particularly prevalent in young women (ie, mean age 44 years) and accounts for 0·5–3% of all strokes. The ...